AIBS has provided testimony to the House Appropriations Committee regarding fiscal year (FY) 2025 funding for the National Science Foundation.
The testimony reads, in part: “Biological research is in our national interest. Increasing our knowledge of how genes, cells, tissues, organisms, and ecosystems function is vitally important to efforts to improve the human condition. Food security, medicine and public health, national security, economic growth, and sound environmental management are informed by the biological sciences. The knowledge gained from NSF-funded research contributes to the development of new research tools and industries.”
AIBS urged Congress to provide NSF with at least $11.9 billion in FY 2025, arguing that this level of funding is “necessary to undo the harmful effects of the slow growth in research funding in recent years that has hurt America’s research productivity.” Citing the 8 percent funding cut the agency received last year, AIBS noted that the FY 2024 allocation “ignores the CHIPS and Science Act, which demonstrated bipartisan commitment to our nation’s scientific and technological enterprise and provided an exciting framework for growing federal investments in research.” The testimony urges Congress to follow through on that commitment by funding NSF as close as possible to the levels authorized by the law.
Read the testimony submitted to House appropriators. A similar letter was submitted to the Senate.
Stay current on the latest science policy news. Subscribe to our bi-weekly AIBS Public Policy Report.